U.S. markets close in 4 hours 56 minutes

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
61.31-1.82 (-2.88%)
As of 11:02AM EDT. Market open.
Sign in to post a message.
  • Y
    Yahoo Finance Insights
    BridgeBio Pharma is up 7.37% to 62.23
  • T
    Travis
    5 different insiders including the CEO who is already very rich, sold millions of dollars of their shares all at once and cratered their stock and caused Wall Street to lose confidence in the stock. Insiders buy when prospects look good, especially the ones who are already wealthy. There is a LOT of suspicion about BBIO and it gave up its breakout completely and is now in a confirmed downtrend. This is a catch the falling knife game now. I wouldn't touch it and made sure to exit when I heard the news about the millions of dollars of stock sold all at once by insiders over the last two months.
  • T
    Travis
    Whoever wanted in and was waiting for a good entry price, today is your day. This stock has a low float so moves are often very exaggerated on the upside or downside.
  • z
    zz
    Lockup expiration is contributing to the down side.
  • j
    james
    Wish I knew about this sooner. I have to wait for a dip to buy in
  • W
    WayneD
    Interesting company. $10B market cap, no earnings. Not much in sales either. So why is this a reasonable investment?
  • C
    Cecil
    It would be nice if their financial forcasting matched their medical results.
    Bearish
  • C
    Craig
    Question - BBIO offered and EIDX board agreed to BBIO buying balance of EIDX shares for $72.
    Since that time, EIDX has gone to 100. What happens?
  • Y
    Yahoo Finance Insights
    BridgeBio Pharma is down 14.24% to 30.11
  • x
    ximenezxim
    A day like this was due to come, In the future. Might there be more Todays ?
  • M
    Mikael
    It’s not just the notes, some short company is pushing down on purpose to get a better buying point. This stock have been shorted so often that is is obvious that they are using red day in their favor!
  • C
    Crecy
    Longs selling.
  • x
    ximenezxim
    $200 Million dollar from Institutional investments gone from yesterday to today. I ¨ve been right not jumping in too early and have waited . No Milestone to be announce closely. Next Objective $25,50 I shall be glad to get that price.
  • T
    Travis
    What a beautiful company! They own Eidos and have several smaller separate biotechs under their banner with lots of clinical stage assets in their pipelines. All Bridge has to do is IPO a few of their smaller companies and they would be worth double what they are now. And looking at recent upside, it looks like suitors must be looking at a possible buyout. Big pharma desperately needs the broad pipelines that BBIO has. On any buyout, it goes for at least double. This is a good play both for speculation and for long term growth, and now it looks like institutional investors are coming in heavily.
  • c
    chhiv-sak
    chart say buy, 26.88 should go back to 30, it s a 3+
  • T
    Tony
    https://uk.reuters.com/article/brief-bridgebio-pharma-inc-files-for-mix/brief-bridgebio-pharma-inc-files-for-mixed-shelf-of-upto-350-mln-idUKFWN2EE0YM

    Raising $350M trying to shore up war chest. This is important as more economic headwinds are expected ahead.
    Neutral
  • x
    ximenezxim
    It only took 4 days to plummet a 23% this must be the biggest Edelman´s flop. and there is no date for milestones.
  • S
    SmooveM
    might be a good entry point, thoughts?
  • N
    Nikhil
    why is stock going down when its subsidiary company EDIOS going. up?
    Neutral
  • Y
    Yahoo Finance Insights
    BBIO is down 14.66% to 19.68